News & Updates
Filter by Specialty:
Molnupiravir speeds up recovery, reduces viral load of vaccinated COVID-19 patients
In vaccinated adults with COVID-19 who are at higher risk of adverse outcomes, treatment with molnupiravir in addition to usual care falls short of reducing the rates of hospitalizations and deaths, as shown by the results of the PANORAMIC study.
Molnupiravir speeds up recovery, reduces viral load of vaccinated COVID-19 patients
21 Apr 2023
Can an antibody-drug conjugate alter the treatment landscape of difficult-to-treat ovarian cancer?
Mirvetuximab soravtansine (MIRV), an antibody drug conjugate (ADC), showed antitumour activity in women with platinum-resistant ovarian cancer* (PROC) with high folate receptor alpha (FRα) expression, findings from the phase III SORAYA study have shown.
Can an antibody-drug conjugate alter the treatment landscape of difficult-to-treat ovarian cancer?
20 Apr 2023
SG: Acne in youths managed suboptimally in primary care
The prescribing patterns for acne among local primary care physicians appear to deviate from clinical practice guidelines used to achieve optimal outcomes for young people, as shown in a Singapore study.
SG: Acne in youths managed suboptimally in primary care
19 Apr 2023
COVID-19 medicine use in pregnancy increases with disease severity
Use of medicines for COVID-19 during pregnancy is higher in patients with more severe disease, according to a study. In addition, a trend towards increased corticosteroids use has been observed and appears to be consistent with changing guidelines.
